Transitional Medicinal Cannabis Regulations ExtendedPosted by On


Transitional medicinal cannabis regulations will be
extended by six months to 30 September 2021 as a result of
COVID-19 to ensure certainty of supply, Health Minister
Andrew Little says.

“The Government is committed to
making the system work and continuing access to prescribed
medicinal cannabis products for patients who need them,”
Andrew Little said.

“Two products from one company
have been verified under the new regulations. However the
Government wants to see multiple suppliers for price
competitiveness.

“COVID-19 restrictions have limited
the abilities of companies to apply under the regulations,
has affected global supply chains and also added challenges
to suppliers seeking to have products assessed.

“I
am mindful of the risk that wholesalers could suspend
imports in advance of the April 1 deadline and this would
prevent patients from accessing prescribed
medicines.

“By extending the deadline, patients will
be still able to access products, while suppliers have the
additional time they need to apply to the Medicinal Cannabis
Agency for verification.

“The Government remains
committed to bringing in the new regulation standards
because patients and doctors deserve to know that medicinal
cannabis products contain what the ingredient list says, are
free from contaminants and are safe to consume,” Andrew
Little said.

The Misuse of Drugs…

Original Author Link click here to read complete story..

Transitional medicinal cannabis regulations will be
extended by six months to 30 September 2021 as a result of
COVID-19 to ensure certainty of supply, Health Minister
Andrew Little says.

“The Government is committed to
making the system work and continuing access to prescribed
medicinal cannabis products for patients who need them,”
Andrew Little said.

“Two products from one company
have been verified under the new regulations. However the
Government wants to see multiple suppliers for price
competitiveness.

“COVID-19 restrictions have limited
the abilities of companies to apply under the regulations,
has affected global supply chains and also added challenges
to suppliers seeking to have products assessed.

“I
am mindful of the risk that wholesalers could suspend
imports in advance of the April 1 deadline and this would
prevent patients from accessing prescribed
medicines.

“By extending the deadline, patients will
be still able to access products, while suppliers have the
additional time they need to apply to the Medicinal Cannabis
Agency for verification.

“The Government remains
committed to bringing in the new regulation standards
because patients and doctors deserve to know that medicinal
cannabis products contain what the ingredient list says, are
free from contaminants and are safe to consume,” Andrew
Little said.

The Misuse of Drugs…



Source link

News

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.